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Abstract
Objective: To assess the effect of age on clinical, endocrine and sonographic features associated with
polycystic ovary syndrome (PCOS) in normogonadotrophic anovulatory infertile women of
reproductive years.
Design: Cross-sectional study.
Methods: Four hundred and seventy-two oligo-amenorrhoeic infertile patients, presenting with
normal FSH and oestradiol concentrations, aged 17–42 years underwent a standardised initial
evaluation including: cycle history, body mass index, waist-to-hip ratio and transvaginal ultrasound
scanning of ovaries. Fasting blood samples were obtained for extensive endocrine evaluation. Cycle
duration, serum levels of gonadotrophins, androgens, oestradiol, insulin, glucose, inhibin B as well as
mean number of follicles, ovarian volume and ovarian stroma echogenicity were assessed.
Results: Older women had significantly lower LH and androgen and inhibin B serum levels. Similarly,
older women presented with a reduced number of ovarian follicles. Age was inversely correlated with
cycle duration r  20:112; P  0:02; LH r  20:154; P  0:001; testosterone r  20:194;
P  0:001; androstenedione r  20:170; P  0:001; dehydroepiandrosterone r  20:157;
P  0:001; insulin r  20:126; P  0:02; inhibin B r  20:118; P  0:03 serum levels and
mean follicle number r  20:100; P  0:03: A positive correlation was observed between age
and glucose to insulin ratio r  0:138; P  0:009:
Conclusions: Advanced age in normogonadotrophic anovulatory infertile women is associated with
lower LH and androgen levels and with a decreased number of ovarian follicles. Although during
reproductive years observed differences are relatively small, these age-related changes may affect the
observed incidence of PCOS.
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Introduction
Demographic and clinical studies show that various
cycle characteristics change with age in normo-
ovulatory women of reproductive age (1, 2). Menstrual
cycles become shorter, due to decreasing follicular
phase length (3). After the age of 35, follicle-stimulat-
ing hormone (FSH) levels begin to increase together
with a subtle decrease in inhibin B without simul-
taneous changes in oestradiol (E2) (4–6). Moreover, a
steady gradual decline with age has been observed in
serum androgens (7). Finally, the number of antral
follicles assessed during the early follicular phase has
recently been shown to decrease with advanced age (8).
The diagnosis of polycystic ovary syndrome (PCOS)
in anovulatory infertile women is usually based on
clinical characteristics in combination with hormonal
and sonographic evaluation. Although hyperandrogen-
aemia seems to play a central role, no agreement has
been reached so far concerning criteria required for
diagnosis (9, 10) and the age of the patients is not
taken into account. Preliminary observations suggest
that a gradual normalisation of menstrual cycle
abnormalities occurs in PCOS patients with increasing
age (11, 12). In contrast, other investigators (13) could
not confirm such changes. Moreover, some studies
recorded a decline in serum androgen levels with age in
hyperandrogenic PCOS patients as well as in controls
(14, 15). Hence, ignoring the patient’s age may result
in over- or under-diagnosis of the syndrome. Notwith-
standing the extensive study of PCOS, little information
is available concerning the potential effect of age
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especially on the extent of cycle abnormality, body
weight and hyperandrogenaemia. The objective of the
present study was to assess the effect of increasing age
on clinical, endocrine and sonographic features associ-
ated with PCOS in a large cohort of normogonado-
trophic oligo-amenorrhoeic infertile patients of
reproductive years.
Materials and methods
Subjects
Four hundred and seventy-two infertile women, attend-
ing our fertility clinic between February 1993 and
September 1999, presenting with oligomenorrhoea
(interval between vaginal bleeding .35 days and #6
months) or amenorrhoea (bleeding interval .6
months) were enrolled in this cross-sectional study.
The study protocol was approved by the human subject
committee of the Erasmus University. Additional inclu-
sion criteria were: (i) FSH levels within normal limits
(1–10 IU/l), and (ii) spontaneous or progestogen-
induced withdrawal bleeding (9, 16). Exclusion criteria
were: (i) serious illnesses such as kidney, liver, heart,
vascular, thyroid diseases, or diabetes mellitus (fasting
glucose .6 nmol/l), (ii) use of exogenous hormones,
(iii) hyperprolactinaemia (PRL.15.5 mg/l), (iv) peri-
ovulatory E2 levels (.400 pmol/l), or (v) luteal phase
progesterone levels (.15 nmol/l).
Standardised clinical screening and transvaginal
sonography (TVS) were performed and a fasting blood
sample was obtained on a random day. Clinical
screening included physical examination, menstrual
and reproductive history, body mass index (BMI), waist-
to-hip ratio (WHR), surgery and previous medication.
BMI was calculated as weight (kg)/height squared (m2).
WHR was defined as the minimum circumference at
the waist divided by the maximum extension over the
buttock, and was utilised as an index for different
patterns of body fat distribution. The contribution of
BMI and WHR on the effect of age on the studied
parameters was evaluated because overweight is more
common in older women.
Endocrine screening included serum measurements
of FSH, luteinising hormone (LH), E2, progesterone,
17-hydroxyprogesterone (17-OHP), testosterone, andro-
stenedione (AD), dehydroepiandrosterone (DHEAS), sex
hormone binding globulin (SHBG), free androgen index
FAI  Testosterone  100=SHBG; insulin, glucose,
inhibin B and cortisol. Fasting blood samples were
taken by venepuncture between 0800 and 1000 h.
Serum was obtained by centrifugation and frozen in
aliquots at 220 8C, for subsequent analysis.
TVS screening included assessment of the ovarian
stroma echogenicity (arbitrarily classified from 1 to 3),
ovarian volume (ml), and total number of antral
follicles (both ovaries), as previously described (9, 17).
Mean follicle number and mean ovarian volume were
calculated as the addition of left and right, divided by
two and total stroma count was the stroma score
addition of the left and the right ovary. For reasons of
comparison PCOS was defined as elevated androgens
(FAI.4.5) and polycystic ovaries (mean ovarian
volume .10.8 ml) (NIH consensus meeting, NIEHS
Durham, NC, USA, September 2000) (9).
Hormone assays
Serum LH and FSH levels were measured by immuno-
radiometric assay (Medgenix, Fleurus, Belgium), and
E2, testosterone, AD, SHBG and DHEAS were deter-
mined using RIA kits (Diagnostic Products Corp., Los
Angeles, CA, USA) as described previously (18). Insulin
was measured by two-site chemiluminescent enzyme-
labelled immunometric assay (Diagnostic Products
Corp.). For inhibin B assays a dimeric immunoassay
kit, solid phase sandwich ELISA (Serotec, Kidlington,
Oxford, UK) was used (19). Intra- and interassay
coefficients of variation were less than 5% and 15%
for LH, less than 3% and 8% for FSH, less than 4% and
7% for E2, less than 6% and 7% for testosterone, less
than 8% and 11% for AD, less than 7% and 8% for
DHEAS, less than 6% and 8% for SHBG, less than 16%
and 17% for progesterone, less than 6% and 10% for
insulin, less than 1% and 2% for glucose, less than 8%
and 14% for inhibin B and less than 9% and 10% for
cortisol respectively
Statistical analysis
All data were analysed for normality of distribution.
Pearson’s correlation test was used when data were
distributed normally. If not, Spearman’s rank correla-
tion test was performed. Covariance analysis was used
to describe the linear relationship between variables
while controlling for the effects of one or more
confounding variables. Student’s t-test or Mann–
Whitney U test were used to compare the means
between subsets of data. The two-tailed P value of
,0.05 was used to define statistical significance.
Results
A total of 472 patients ranging between 17 and 42
years of age (28:5^4:5 years) were evaluated in this
study. Clinical, endocrine and ultrasound character-
istics of these 472 women are presented in Table 1.
Women were also grouped by age: 17–29 and $30–42
years. Differences for LH, LH/FSH ratio, testosterone,
AD, DHEAS, mean number of follicles and the
percentage of PCOS subjects were found to be
statistically significant (Table 1).
In the study population, age was inversely correlated
with cycle duration, LH, testosterone, AD, DHEAS, FAI,
SHBG, insulin, inhibin B levels and mean follicle
number (Table 2). Bivariate correlations between age
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and biologically pertinent parameters such as cycle
duration, LH, FSH, androgens and inhibin B are
depicted in Figs 1–3.
No significant correlation between age and E2 levels
was found; neither between age and BMI, WHR, mean
ovarian volume, nor total stroma score (Table 2). No
changes in correlations of all the aforementioned
parameters with age were observed when patients
were grouped and analysed according to the cycle
duration (oligomenorrhoeic vs amenorrhoeic women;
data not shown).
Covariance analysis to evaluate the relative con-
tribution of BMI and WHR on the effect of age on the
studied parameters revealed no differences in the
strength of correlation among these variables (data
not shown).
Discussion
Although abnormalities observed in PCOS have been
studied extensively, little information is available
concerning possible changes in clinical, endocrine
and sonographic features associated with increasing
age. In the current cross-sectional study in a large
cohort of normogonadotrophic anovulatory infertile
women, weak but statistically significant inverse
correlations were observed between age and cycle
duration, LH, androgens, SHBG, insulin, inhibin B and
Table 1 Clinical, endocrine and sonographic features (mean^S.D.) in 472 normogonadotrophic oligo-amenorrhoeic infertile patients,
and separately for women below or above 30 years of age.
Overall group
n  472
17–29 years
n  302
30–42 years
n  170 P value*
Clinical
Age (years) 28.5^4.4 25.8^2.8 33.2^2.5
Amenorrhoea (n)† 115 (24%) 72 (24%) 42 (25%) NS
Cycle duration in oligomenorrhoeic patients (days) 92^67 93^68 89^67 NS
BMI (kg/m2) 27.0^6.6 27.2^7.0 26.8^6.0 NS
WHR 0.8^0.01 0.8^0.01 0.8^0.01 NS
Endocrine
LH (IU/l) 7.6^4.6 8.0^4.8 6.9^4.3 0.016
FSH (IU/l) 4.8^1.5 4.8^1.5 4.8^1.4 NS
E2 (pmol/l) 210^75 212^73 205^77 NS
Inhibin B (ng/l) 143^98 150^101 130^90 0.05
Testosterone (nmol/l) 2.4^1.0 2.5^1.0 2.2^0.9 0.003
AD (nmol/l) 14.3^6.9 15.0^7.3 13.0^6.0 0.002
DHEAS (umol/l) 7.1^3.4 7.5^3.4 6.5^3.2 0.001
FAI 6.9^7.1 7.2^5.9 6.3^8.6 NS
SHBG (nmol/l) 51.3^33.3 49.5^31.9 55.5^35.4 0.06
Glucose (mmol/l) 4.4^1.6 4.3^1.6 4.5^1.6 NS
Insulin (mIU/l) 15.1^12.0 15.8^13.1 13.9^9.8 NS
Glucose/insulin (mmol/mIU) 0.4^0.3 0.4^0.3 0.5^0.3 NS
Cortisol (nmol/l) 397^158 400^159 391^157 NS
Transvaginal sonography
Mean ovarian volume (ml) 9.3^4.6 9.4^4.6 9.1^4.6 NS
Mean follicle number (n) 12.5^6.2 12.9^6.0 11.7^6.4 0.05
PCO (n)† 99 (21%) 78 (26%) 22 (13%) 0.001
*Student’s t-test for normally distributed values; Mann–Witney U test when not normally distributed. NS  not significant.
†Percentages of women presenting with amenorrhoea or PCO were compared using Chi-square test.
Table 2 Bivariate correlations between age and clinical, endocrine
and sonographic characteristics of 472 normogonadotrophic
oligo-amenorrhoeic infertile patients of reproductive age.
r value* P value
Clinical
Cycle duration† 20.112 0.017
BMI (kg/m2) 20.004 NS
WHR 0.114 NS
Endocrine
LH (IU/l) 20.154 0.001
FSH (IU/l) 0.023 NS
OE2 (pmol/l) 20.033 NS
Inhibin B (ng/l) 20.118 0.026
Testosterone (nmol/l) 20.194 0.001
AD (nmol/l) 20.170 0.001
DHEAS (mmol/l) 20.157 0.001
FAI 20.158 0.001
SHBG (nmol/l) 20.107 0.02
Glucose (mmol/l) 0.039 NS
Insulin (mIU/l) 20.126 0.015
Glucose/insulin ratio (mmol/mIU) 0.138 0.009
Cortisol (nmol/l) 20.009 NS
Transvaginal sonography
Mean ovarian volume (ml) 20.026 NS
Mean follicle number (n) 20.100 0.034
Total stroma score* 20.005 NS
*Spearman’s rank correlation.
†Defined as number of days between spontaneous menses (oligomenor-
rhoeic women only). NS=not significant.
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mean number of ovarian follicles. In addition, LH,
testosterone, AD, and DHEAS concentrations were
decreased in women over 30 years compared with
younger women. Moreover, the mean number of
follicles was significantly decreased and polycystic
ovaries were less frequently encountered in older
women.
The slight decline in cycle duration with increasing
age that we found may be related to the simultaneous
fall in androgens. It is known that both normal weight
and obese oligomenorrhoeic hirsute patients exhibit
higher testosterone and FAI levels compared with
normo-ovulatory hirsute women (20, 21). Thus, it
seems that androgen levels are correlated more with
menstrual pattern than with patient’s weight. We
could not confirm a positive correlation between age
and BMI, as described previously (22). This may be
explained by the inclusion of anovulatory rather than
Figure 2 Bivariate correlations between testosterone, AD and
DHEAS serum concentrations with age in 472 normogonadotrophic
oligo-amenorrhoeic infertile patients.
Figure 1 Bivariate correlations between LH and FSH serum
concentrations with age in 472 normogonadotrophic
oligo-amenorrhoeic infertile patients.
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normally cycling women and by the relatively young
age of the current study population.
Data from the present cross-sectional study do not
provide strong evidence that the incidence of cycle
abnormalities in PCOS women is related to their age. In
contrast, other longitudinal studies (11, 12) suggested
that cycle abnormalities tend to normalise with age.
This discrepancy may again be due to differences in age
of the patients studied, but also differences in study
design, and criteria used to diagnose PCOS. Moreover,
women with cycle abnormalities at advanced age are
more likely to use steroid contraceptives and therefore
their spontaneous cycle cannot be assessed in longi-
tudinal follow-up studies. Indeed, the number of
dropouts from reported follow-up studies is very high.
However, it should be emphasised that the current
cross-sectional study does not rule out cycle changes
over time.
In normal women of reproductive age, the negative
relationship of age with serum androgens has been
established by previous investigators (6, 23). In
addition, it has been shown that in hirsute hyper-
androgenic women, the negative association between
testosterone, AD, DHEAS levels and age is preserved
(15). Our observations confirm these previous findings
and suggest that the age of the patients should be taken
into consideration when evaluating the hormonal
profile of normogonadotrophic anovulatory infertile
patients. The weak correlations found do not permit us
to interpret these data as disease amelioration, but
rather a physiological decline also observed in healthy
women. It has been suggested that both adrenal and
ovarian contributions to serum androgens decline with
age (24).
In the current study, fasting serum insulin concen-
trations were not consistently increased and average
levels were within the normal range as observed in
other studies (25, 26). Hyperinsulinaemia is most
prominent in obese PCOS patients (27) and the present
study included both lean and obese women. A weak
positive correlation between age and fasting glucose to
insulin ratio was observed, suggesting that a slight
amelioration of insulin resistance may occur with age.
This is in accordance with a gradual decline in
androgen levels with age since insulin may be directly
involved in androgen production at the ovarian level
(28).
LH concentrations were reported to remain
unchanged in women with regular menstrual cycles,
even above 45 years of age (29). Other studies reported
a rise in LH, almost simultaneous with FSH (30). The
finding of a weak inverse relationship between age and
LH in the current study in anovulatory women is
unexpected and surprising. A statistically significant
decrease in LH levels was also observed when young
women were compared with those above 30 years of
age. In a recent 10-year follow-up study (31) gonado-
trophin levels were significantly reduced in PCOS
Figure 3 Bivariate correlations between parameters associated
with normal ovarian ageing – cycle duration, mean follicle number
and serum inhibin B concentrations – with age in 472
normogonadotrophic oligo-amenorrhoeic infertile patients.
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patients using oestrogen–progestogen compounds, but
showed no decline in non-users. Another study (13)
was unable to find differences in gonadotrophin levels
comparing adolescent and adult PCOS patients. Recent
work from our group suggest that initial LH concen-
trations do not predict ovarian responsiveness to
ovulation induction, indirectly opposing the concept
that elevated LH levels are involved in ovarian
dysfunction in these patients (18). Moreover, a single
assessment of LH levels is of limited significance due to
the timing of blood sampling, immunoassays used and
the pulsatile nature of LH secretion (32). For all the
aforementioned reasons, the pathophysiological rele-
vance of the observed slight decline in LH with
increasing age remains uncertain.
It is well established that in normal women the
depletion of ovarian follicles continues during the
reproductive years until the supply of resting primordial
follicles is exhausted (1). Indeed, in normo-ovulatory
women the number of antral follicles assessed by
ultrasound decreases with age (8, 33). In PCOS only
advanced stages of follicle maturation are arrested,
resulting in an increased number of small antral
follicles (34). No information is available concerning
the extent of follicle depletion or menopausal age in
PCOS women. In the current study in anovulatory
women we found for the first time a reduction in follicle
number with increasing age, in line with normo-
ovulatory women. Combining these observations con-
cerning LH, androgens and mean follicle numbers and
defining PCOS as polycystic ovaries and elevated LH
and androgen levels, the incidence of PCOS in normo-
ovulatory infertile women may decrease over time.
The pattern of FSH and inhibin B secretion in normal
women of reproductive age has previously been
characterised (1, 4, 30, 35). FSH begins to rise at the
age of 35 with a marked increase beyond 40 years.
Inhibin B demonstrates a slight drop at the age of 35
and declines thereafter (29, 35). Moreover, inhibin B
serum levels are normal in normogonadotrophic
anovulatory women as well as in PCOS patients (36).
In the current study, anovulatory women with elevated
or reduced FSH were excluded since these groups
represent different aetiological entities such as pre-
mature menopause. However, the normal range for
FSH is wide (1–10 IU/l) and age-related changes may
be established. From our data (showing no correlation
of age with FSH and a weak inverse correlation with
inhibin B) we can conclude that inhibin B secretion in
normogonadotrophic anovulatory women follows the
same pattern as in healthy women. A direct inverse
correlation between inhibin B and FSH could not be
confirmed.
In conclusion, the combined data of the current
cross-sectional study do indicate appreciable changes in
clinical, endocrine and ovarian characteristics associ-
ated with PCOS with increasing age in WHO class II
anovulatory patients of reproductive age. It seems that
observed minor changes follow the same pattern as in
normo-ovulatory women of similar age. These changes
may affect the observed incidence of PCOS. A longi-
tudinal follow-up study should confirm these observa-
tions and should further establish the precise timing
and magnitude of observed alterations.
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